April 01, 2026 06:28 pm (IST)
Zydus Cadila receives USFDA approval to market Carboplatin Injection
Ahmedabad, Apr 1 (IBNS) Zydus Cadila, a fully integrated, global healthcare provider, announced on Friday that it has received the final approval from the USFDA to market Carboplatin Injection, 10 mg/ml in 5 ml, 15 ml and 45 ml.
The group now has more than 100 approvals and has so far filed over 280 ANDAs since the commencement of the filing process in FY 2003-04.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Fuel prices rise: Premium petrol, diesel hiked amid oil price surge
Wed, Apr 01 2026
Defence PSU boom! Garden Reach Shipbuilders & Engineers stock rockets 20%—what’s driving the surge?
Wed, Apr 01 2026
Dalal Street on fire: Sensex soars, Nifty rockets—here’s why!
Wed, Apr 01 2026
Layoff alert: Oracle cuts 30,000 jobs globally, 12,000 hit in India
Wed, Apr 01 2026
PwC India announces leadership transition in Deals Business
Tue, Mar 31 2026
DBS Bank India launches relationship-led banking for 'India’s globally mobile, emerging affluent'
Tue, Mar 31 2026
Major expansion ahead: Govt clears 29 proposals under ECMS
Tue, Mar 31 2026
